ATI-V Program for Preventing Adolescent Vaping
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial focuses on finding effective ways to prevent adolescents from starting or continuing to use electronic vaping products (EVPs). The study tests an intervention called Above the Influence-Vaping (ATI-V), where 8th and 9th-grade students train as peer leaders to conduct school-wide campaigns against vaping, with adult guidance. The trial aims to determine if these peer-led campaigns can successfully reduce vaping among teenagers. Eligible participants include 8th-grade students who speak English and attend a participating school. As an unphased trial, this study offers a unique opportunity to contribute to important research that could help peers make healthier choices.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that this intervention is safe for adolescents?
Research shows that the "Above the Influence-Vaping" (ATI-V) program aims to prevent vaping among teens by training peer leaders to share anti-vaping messages in schools. However, specific safety data for the ATI-V program itself is not available.
The ATI-V program is a school-based educational effort and does not involve medical treatments or drugs. Therefore, it lacks typical safety concerns like side effects associated with medications. The program focuses on teaching students to support each other in avoiding vaping through communication and encouragement.
Since this is not a medical treatment, the primary focus is on its effectiveness in reducing vaping among teens. Safety concerns, as seen with new drugs, do not apply here. Instead, the goal is to evaluate how well the program prevents kids from starting to vape.12345Why are researchers excited about this trial?
Researchers are excited about the ATI-V program because it aims to tackle adolescent vaping by proactively educating students before habits form. Unlike traditional approaches that often focus on cessation after vaping begins, ATI-V integrates prevention into the school curriculum, engaging students over two school years. This early intervention strategy is designed to provide lasting prevention by embedding anti-vaping messages and skills at a critical developmental stage.
What evidence suggests that the ATI-V program is effective for preventing adolescent vaping?
Research has shown that the Above the Influence-Vaping (ATI-V) program might help reduce vaping among teenagers. In early tests, student leaders encouraged their classmates not to vape. These leaders shared anti-vaping messages, fostering a supportive environment against vaping. Although some studies have shown mixed results for school-based vaping prevention, the ATI-V program's focus on peer influence is unique and promising. In this trial, participants will receive either the Immediate ATI-V Intervention or the Delayed ATI-V Intervention. Overall, the ATI-V approach could effectively lower vaping rates among young people.16789
Are You a Good Fit for This Trial?
This trial is for current 8th grade students in a participating school, regardless of race, color, national origin, sexual orientation, sex, gender identity, age or ability. Non-English speaking students cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Immediate Intervention
School receives Above the Influence-Vaping (ATI-V) prevention program training after baseline assessment. Training and intervention continue over two school years.
Delayed Intervention
ATI-V prevention program training after 4th assessment, following a wait-list period.
Follow-up
Participants are monitored for changes in vaping behavior and attitudes after intervention
What Are the Treatments Tested in This Trial?
Interventions
- Above the Influence-Vaping (ATI-V)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Rochester
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
Penn State University
Collaborator
Claremont Graduate University
Collaborator
Texas Tech University
Collaborator
University of North Carolina, Chapel Hill
Collaborator